Meta-analysis - Eltrombopag

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Thrombocytopaenia

Treatments: Drug: Eltrombopag; Drug: Placebo

Study type: Observational

Funder types: Industry

Identifiers

NCT01235988

114013

Details and patient eligibility

About

The purpose of the meta-analysis was to explore the efficacy of eltrombopag versus placebo (standard of care)

Full description

Meta-analysis of three studies: Bussell 2007 & Bussell 2009 & RAISE (TRA102537).

Enrollment: 1 patient

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults with ITP
• Received a pre-specified treatment
• Prospective clinical studies with at least 10 patients

Exclusion criteria

• Subjects with ITP due to other causes

Trial design

1 participants in 2 patient groups

Eltrombopag & standard of care

Treatment:

Drug: Eltrombopag

Standard of care

Treatment:

Drug: Placebo